Skip to content

Bristol-Myers Squibb BMY Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin281.3%-15.8pp297.1%-10.4pp307.5%-8.1pp315.6%+9.8pp
Net margin48.7%+110pp-61.5%-131pp69.8%+14.5pp55.3%+78.1pp
Returns
Return on equity134.4%+257pp-123%-224pp101.1%+26.0pp75.1%+94.6pp
Return on invested capital40.2%+85.9pp-45.6%-101pp55%+9.9pp45%+50.2pp
Efficiency
Asset turnover0.0×+0.1×1.9×+0.1×1.8×+0.3×
Liquidity
Current ratio+0.2×4.8×-0.7×5.4×0.0×5.4×-0.7×
Leverage
Debt-to-equity10.9×-1.6×12.5×+7.3×5.2×-0.1×5.3×+0.3×
Net debt / EBITDA11×-65.2×76.2×+69.5×6.6×-0.6×7.2×-10.2×
Valuation
Market capitalization$421.42B+1.9%$413.46B-18.3%$505.78B-18.9%$623.91B+11.8%
Price / earnings73.4×64.5×-32.1×96.5×
Price / sales8.8×0.0×8.8×-2.4×11.2×-2.2×13.3×+0.9×
Price / book23.5×-1.2×24.7×+8.2×16.5×-3.0×19.5×+4.4×
EV / EBITDA42.7×-226×268.2×+234×33.9×-8.0×41.8×-46.7×
Dividend yield19.2%+0.3pp18.8%+3.7pp15.1%+3.4pp11.7%-0.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Bristol-Myers Squibb's ratios come from?
Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.